Facebook
Twitter
LinkedIn
ForwardLive event - Autism Spectrum Disorder Conference, 16th Annual
CDC estimated that an average of one in 68 children in the U.S has an autism spectrum disorder. CDC is working to find out how many children have autism spectrum disorders, discover the risk factors, and raise awareness of the signs. The need for autism-specific screening during pediatric well-child visits has been established. However, additional support for specific screening instruments is needed. Dr. Luis Carcache will discuss tools to identify autism spectrum disorders in a primary care setting, and Dr. Daniel Castellanos will address best practices for psychotropic medication use for children and adolescents.
Target Audience
Pediatricians, Neurologists, Family Practice Physicians, Psychologists, Psychiatrists, Hospitalists, Nurses, Respiratory Therapists, Social Workers, and Occupational Therapists.
Learning Objectives
- Describe diagnostic criteria for an autism spectrum disorder based on The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
- Name screening instruments used to identify children with an autism spectrum disorder in a primary care setting.
- Describe referral and service options available when a child receives a diagnosis of an autism spectrum disorder.
- Recognize the common behavioral symptoms seen in children with autism spectrum disorder that may be a focus of psychotropic medication use.
- Identify medication treatment of these behavioral symptoms and with emphasis on evidence-based use of medications.
Luis Carcache, M.D.
Assistant Professor, Child and Adolescent Psychiatry
Florida International University Herbert Wertheim College of Medicine
Daniel Castellanos, M.D.
Assistant Dean, Graduate Medical Education; Founding Chair and Professor, Department of Psychiatry & Behavioral Health; Secondary Appointment as Professor, Department of Pediatrics
Florida International University Herbert Wertheim College of Medicine
Dr. Carcache indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation or discussions.
Dr. Castellanos indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation or discussions.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 2 credit hours, CE Broker Course #20-568619, by the Florida Boards of Medicine, Osteopathic Medicine and Psychology (2 hours).
This activity has also been approved for 2 credits for Nursing, Nurse Practitioners, Occupational Therapy, Respiratory Therapy (personal growth) and Social Work, Marriage and Family Therapy and Mental Health Counseling. Baptist Health South Florida CE Broker Provider #50-182.
Required Hardware/Software
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.